Year: 2014
Type: review
Abstract: Idiopathic pulmonary fibrosis (IPF) is the most common form of interstitial lung disease characterized by the persistence of activated myofibroblasts resulting in excessive deposition of extracellular matrix proteins and profound tissue remodeling. Myofibroblasts have been shown to arise from interstitial fibroblasts, epithelial to mesenchymal transition of type II alveolar epithelial cells, and the differentiation of recruited fibrocytes. There are many mechanisms that are utilized by these cells for survival, proliferation, and persistent activation including up-regulation of cytokines [i.e., Interleukin 6 (IL-6) and C-C motif chemokine ligand 21 (CCL21)], cytokine receptors [i.e., Interleukin 6Receptor 1 (IL-6R1), Glycoprotein 130 (gp130) and C-C Chemokine Receptor type 7 (CCR7)], and innate pattern recognition receptors [(PRRs; i.e., Toll Like Receptor 9 (TLR9)]. In this review, we will discuss the role of the cytokines IL-6 and CCL21, their receptors and the PRR, TLR9, in fibroblast recruitment, activation, survival, and differentiation into myofibroblasts in IPF.
Source: Frontiers in Pharmacology
Authors: David M. Habiel, Cory Hogaboam
Institution: Cedars-Sinai Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: idiopathic pulmonary fibrosis, myofibroblast activation, fibroblast proliferation, fibroblast survival, fibroblast heterogeneity, interleukin-6, CCL21, IL-6 receptor, gp130, CCR7, TLR9, pattern recognition receptors, fibroblast recruitment, interstitial lung disease, tissue remodeling, extracellular matrix deposition
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W1982886107
